Published in J Clin Densitom on January 01, 2003
Cortical and trabecular architecture are altered in postmenopausal women with fractures. Osteoporos Int (2009) 1.03
Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls. Arthritis Care Res (Hoboken) (2012) 0.93
Imaging-Based Methods for Non-invasive Assessment of Bone Properties Influenced by Mechanical Loading. Physiother Can (2012) 0.87
A trimodality comparison of volumetric bone imaging technologies. Part I: Short-term precision and validity. J Clin Densitom (2014) 0.82
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. Trials (2006) 0.78
Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskelet Disord (2013) 0.77
The Relationship between Radial Bone Properties and Disease Activity and Physical Function in Individuals with Rheumatoid Arthritis. Physiother Can (2012) 0.76
A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part III: SD, SEE, LSC Association With Fragility Fractures. J Clin Densitom (2014) 0.75
Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis. Exp Ther Med (2017) 0.75
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med (2007) 4.68
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res (2004) 2.15
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem (2009) 1.85
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol (2009) 1.70
Diagnosis and management of vertebral fractures in elderly adults. Am J Med (2002) 1.68
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res (2014) 1.62
Effect of low-intensity pulsed ultrasound on the cartilage repair in people with mild to moderate knee osteoarthritis: a double-blinded, randomized, placebo-controlled pilot study. Arch Phys Med Rehabil (2012) 1.60
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab (2002) 1.59
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom (2004) 1.59
Intrarater reliability of dual-energy X-ray absorptiometry-based measures of vertebral height in postmenopausal women. J Clin Densitom (2012) 1.56
Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol (2008) 1.55
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. J Bone Joint Surg Am (2012) 1.54
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res (2010) 1.54
Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns (2002) 1.53
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging (2007) 1.44
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). J Clin Endocrinol Metab (2014) 1.41
Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey. J Obstet Gynaecol Can (2004) 1.38
Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int (2005) 1.31
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res (2012) 1.29
Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res (2007) 1.28
Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord (2005) 1.27
Predicting fractures in an international cohort using risk factor algorithms without BMD. J Bone Miner Res (2011) 1.22
Reproducibility of DXA measurements of bone mineral density and body composition in children. Pediatr Radiol (2008) 1.22
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res (2014) 1.19
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res (2012) 1.18
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther (2004) 1.17
Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res (2009) 1.17
Do patients perceive a link between a fragility fracture and osteoporosis? BMC Musculoskelet Disord (2008) 1.16
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep (2013) 1.11
Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. J Clin Epidemiol (2006) 1.09
Predicting the failure load of the distal radius. Osteoporos Int (2003) 1.09
Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporos Int (2003) 1.09
The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population. Qual Life Res (2006) 1.08
Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2004) 1.06
Fracture risk in living kidney donors: a matched cohort study. Am J Kidney Dis (2012) 1.06
Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review. Drug Saf (2002) 1.06
Can body weight supported treadmill training increase bone mass and reverse muscle atrophy in individuals with chronic incomplete spinal cord injury? Appl Physiol Nutr Metab (2006) 1.06
An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis (2012) 1.06
Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2011) 1.05
Prediction of falls using a risk assessment tool in the acute care setting. BMC Med (2004) 1.05
Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med (2002) 1.05
Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. J Am Geriatr Soc (2013) 1.05
Bridging the osteoporosis quality chasm. J Bone Miner Res (2009) 1.03
Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr (2009) 1.01
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res (2009) 1.00
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone (2008) 1.00
Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis. Ther Clin Risk Manag (2011) 1.00
Impact of occupational exposure on lead levels in women. Environ Health Perspect (2005) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Minimum joint space width and tibial cartilage morphology in the knees of healthy individuals: a cross-sectional study. BMC Musculoskelet Disord (2008) 0.99
An interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial. Implement Sci (2012) 0.98
Whole-body bone mineral content, lean body mass, and fat mass measured by dual-energy X-ray absorptiometry in a population of normal Canadian children and adolescents. Can Assoc Radiol J (2007) 0.98
Determinants of health-related quality of life in women with vertebral fractures. Osteoporos Int (2005) 0.97
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nat Clin Pract Rheumatol (2008) 0.97
Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging Clin Exp Res (2008) 0.97
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskelet Disord (2010) 0.96
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2011) 0.96
A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents. PLoS One (2010) 0.95
Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone (2012) 0.95
Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. J Bone Miner Res (2012) 0.94
Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab (2013) 0.93
Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskelet Disord (2002) 0.92
Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CMAJ (2010) 0.92
Once-yearly zoledronic acid in older men compared with women with recent hip fracture. J Am Geriatr Soc (2011) 0.92
Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36. Can J Public Health (2010) 0.91
Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord (2005) 0.91
Grid search: an innovative method for the estimation of the rates of lead exchange between body compartments. J Environ Monit (2005) 0.91
Diagnosis and treatment of Paget's disease of bone. Clin Invest Med (2007) 0.90
What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos. J Clin Densitom (2006) 0.90
Surgical preferences of patients at risk of hip fractures: hemiarthroplasty versus total hip arthroplasty. BMC Musculoskelet Disord (2011) 0.90
Prevalence of osteoporosis in osteoarthritic patients undergoing total hip or total knee arthroplasty. Arch Phys Med Rehabil (2008) 0.90
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone (2011) 0.90
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disord (2010) 0.90
Adapting the Iconic Pain Assessment Tool Version 2 (IPAT2) for adults and adolescents with arthritis pain through usability testing and refinement of pain quality icons. Clin J Pain (2013) 0.89
Measurement of cervical flexor endurance following whiplash. Disabil Rehabil (2005) 0.89
The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). BMC Med Educ (2009) 0.89
Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporos Int (2004) 0.88
Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture. Ther Adv Musculoskelet Dis (2009) 0.88
Stability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians. Can J Public Health (2004) 0.87
Benefit-risk assessment of raloxifene in postmenopausal osteoporosis. Drug Saf (2005) 0.87
Hip fracture prevention strategies in long-term care: a survey of Canadian physicians' opinions. Can Fam Physician (2010) 0.87
Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents. J Cachexia Sarcopenia Muscle (2011) 0.87
How to define responders in osteoarthritis. Curr Med Res Opin (2013) 0.86
Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease. Drug Saf (2006) 0.86
Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy. Radiat Prot Dosimetry (2006) 0.86
Measurement equivalence of the SF-36 in the Canadian Multicentre Osteoporosis Study. Health Qual Life Outcomes (2012) 0.86
The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study. BMC Musculoskelet Disord (2013) 0.85
Improvement in health-related quality of life in osteoporosis patients treated with teriparatide. BMC Musculoskelet Disord (2008) 0.85
What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention? BMC Geriatr (2010) 0.85
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom (2011) 0.84
Raloxifene use in clinical practice: efficacy and safety. Menopause (2009) 0.84
Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcif Tissue Int (2014) 0.83